Press Releases August 6, 2026 06:40 AM

TransUnion Declares Second Quarter 2026 Dividend of $0.125 per Share

TransUnion announces Q2 2026 dividend payment of $0.125 per share

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
TRU

TransUnion's Board of Directors declared a second quarter dividend of $0.125 per share, payable on September 4, 2026, to shareholders of record on August 20, 2026. The company emphasizes its global reach and innovation in credit, marketing, fraud, risk, and advanced analytics solutions.

TransUnion Declares Second Quarter 2026 Dividend of $0.125 per Share
TRU
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • TransUnion declared a quarterly cash dividend of $0.125 per share for Q2 2026.
  • Dividend payable on September 4, 2026, to shareholders of record as of August 20, 2026.
  • Company highlights its global presence and technology investments in credit and analytics sectors.

CHICAGO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- TransUnion (NYSE: TRU) today announced that its Board of Directors declared a cash dividend of $0.125 per share for the second quarter 2026. The dividend will be payable on September 4, 2026, to shareholders of record on August 20, 2026.

About TransUnion (NYSE: TRU)

TransUnion is a global information and insights company with over 13,000 associates operating in more than 30 countries. We make trust possible by ensuring each person is reliably represented in the marketplace. We do this with a Tru™ picture of each person: an actionable view of consumers, stewarded with care. Through our acquisitions and technology investments we have developed innovative solutions that extend beyond our strong foundation in core credit into areas such as marketing, fraud, risk and advanced analytics. As a result, consumers and businesses can transact with confidence and achieve great things. We call this Information for Good® — and it leads to economic opportunity, great experiences and personal empowerment for millions of people around the world.

http://www.transunion.com/business

ContactGreg Bardi, Investor RelationsE-mail[email protected] Telephone312-985-2860



Risks

  • No financial performance details accompany the dividend declaration, leaving uncertainty about future earnings.
  • Market conditions or regulatory changes in credit reporting and analytics sectors could impact business.
  • Competition in fintech and data analytics could affect TransUnion's market position.

More from Press Releases

Corbus Pharmaceuticals Reports Q2 2026 Financial Results and Provides a Corporate Update Aug 6, 2026 ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update Aug 6, 2026 Theriva™ Biologics Announces First Patient Dosed in VIRAGE2 Phase 2a Clinical Trial to Evaluate More Frequent Dosing of VCN-01 (zabilugene almadenorepvec) in First-Line Patients with Metastatic Pancreatic Ductal Adenocarcinoma Aug 6, 2026 Ascendis Announces COACH Week 78 Results and Provides Update on Achondroplasia Programs and YUVIWEL® Uptake in the U.S. Aug 6, 2026 Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results Aug 6, 2026